Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Ewing Sarcoma
- Neuroblastoma
- Osteosarcoma
- Recurrent or Refractory Solid Tumors
- Rhabdomyosarcoma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 1220 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02013336
- Collaborators
- Not Provided
- Investigators
- Study Chair: Paul Harker-Murray, MD Midwest Children's Hospital
Get Well Soon